Fan X, Wang J, Chen S, Li X, Cao J, Wang H
Sci Rep. 2025; 15(1):4748.
PMID: 39922934
PMC: 11807197.
DOI: 10.1038/s41598-025-89217-4.
Liu Y, Ji H, Wu L, Wang X, Yang Y, Zhang Q
Mol Ther Oncol. 2024; 32(4):200890.
PMID: 39498358
PMC: 11532917.
DOI: 10.1016/j.omton.2024.200890.
Du H, Zhu K
Technol Health Care. 2024; 32(6):4707-4725.
PMID: 39302398
PMC: 11613018.
DOI: 10.3233/THC-240932.
Ou J, Yin H, Shu F, Wu Z, Liu S, Ye J
Heliyon. 2024; 10(16):e36235.
PMID: 39247316
PMC: 11380016.
DOI: 10.1016/j.heliyon.2024.e36235.
Xu S, Zhang Y, Yang Y, Dong K, Zhang H, Luo C
Front Immunol. 2024; 15:1374465.
PMID: 39119345
PMC: 11306056.
DOI: 10.3389/fimmu.2024.1374465.
Comprehensive Analysis of a Six-Gene Signature Predicting Survival and Immune Infiltration of Liposarcoma Patients and Deciphering Its Therapeutic Significance.
Han J, Zhao B, Han X, Sun T, Yue M, Hou M
Int J Mol Sci. 2024; 25(14).
PMID: 39063036
PMC: 11277418.
DOI: 10.3390/ijms25147792.
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancer.
Wu H, Wu Z, Li H, Wang Z, Chen Y, Bao J
Front Immunol. 2024; 15:1392940.
PMID: 39015576
PMC: 11249538.
DOI: 10.3389/fimmu.2024.1392940.
Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning-derived signature for improving outcomes in gliomas.
Li Y, Zhang Y, Feng S, Zhu H, Xing Y, Xiong X
CNS Neurosci Ther. 2024; 30(7):e14816.
PMID: 38948951
PMC: 11215471.
DOI: 10.1111/cns.14816.
Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study.
Zhou X, Ling Y, Cui J, Wang X, Long N, Teng W
Sci Rep. 2024; 14(1):12602.
PMID: 38824202
PMC: 11144219.
DOI: 10.1038/s41598-024-63592-w.
Molecular characterization, clinical value, and cancer-immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer.
Liu X, Li D, Gao W, Chen P, Liu H, Zhao Y
Discov Oncol. 2024; 15(1):183.
PMID: 38787520
PMC: 11126553.
DOI: 10.1007/s12672-024-01031-y.
Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer.
Sun X, Li L, Yang X, Ke D, Zhong Q, Zhu Y
Heliyon. 2024; 10(9):e30277.
PMID: 38707466
PMC: 11068819.
DOI: 10.1016/j.heliyon.2024.e30277.
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Ren X, Cui H, Dai L, Chang L, Liu D, Yan W
J Cancer Res Clin Oncol. 2024; 150(3):119.
PMID: 38466449
PMC: 10927816.
DOI: 10.1007/s00432-024-05626-4.
Identification of an angiogenesis-related risk score model for survival prediction and immunosubtype screening in multiple myeloma.
Yu M, Ming H, Xia M, Fu J, Cai Z, Cui X
Aging (Albany NY). 2024; 16(3):2657-2678.
PMID: 38319724
PMC: 10911366.
DOI: 10.18632/aging.205502.
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
Ding M, Ran X, Qian S, Zhang Y, Wang Z, Dong M
Aging (Albany NY). 2024; 15(24):15360-15381.
PMID: 38180104
PMC: 10781490.
DOI: 10.18632/aging.205354.
Integrated analysis of bulk RNA-seq and single-cell RNA-seq reveals the function of pyrocytosis in the pathogenesis of abdominal aortic aneurysm.
Zhao S, Cang H, Liu Y, Huang Y, Zhang S
Aging (Albany NY). 2023; 15(24):15287-15323.
PMID: 38112597
PMC: 10781497.
DOI: 10.18632/aging.205350.
Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning.
Wu H, Wu Z, Ye D, Li H, Dai Y, Wang Z
Front Oncol. 2023; 13:1246880.
PMID: 38023262
PMC: 10661325.
DOI: 10.3389/fonc.2023.1246880.
Identification of aneuploidy-related gene signature to predict survival in head and neck squamous cell carcinomas.
Liu Y, Yuan Y, Chen T, Xiao H, Zhang X, Zhang F
Aging (Albany NY). 2023; 15(22):13100-13117.
PMID: 37988195
PMC: 10713391.
DOI: 10.18632/aging.205221.
Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer.
Li Z, Liu Y, Guo P, Wei Y
Aging (Albany NY). 2023; 15(21):12413-12450.
PMID: 37938164
PMC: 10683615.
DOI: 10.18632/aging.205189.
Integrative evaluation and experimental validation of the immune-modulating potential of dysregulated extracellular matrix genes in high-grade serous ovarian cancer prognosis.
Wu Q, He X, Liu J, Ou C, Li Y, Fu X
Cancer Cell Int. 2023; 23(1):223.
PMID: 37777759
PMC: 10543838.
DOI: 10.1186/s12935-023-03061-y.
Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
Li J, Wan C, Li X, Quan C, Li X, Wu X
J Transl Med. 2023; 21(1):647.
PMID: 37735483
PMC: 10515034.
DOI: 10.1186/s12967-023-04505-9.